Guardian Capital (Canada)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-1,343
Closed -$367K – 178
2018
Q1
$367K Sell
1,343
-30
-2% -$9.31K 0.01% 159
2017
Q4
$437K Buy
1,373
+504
+58% +$162K 0.01% 141
2017
Q3
$272K Buy
+869
New +$257K ﹤0.01% 186
2017
Q1
– Sell
-719
Closed -$204K – 206
2016
Q4
$204K Sell
719
-124
-15% -$36.8K ﹤0.01% 212
2016
Q3
$264K Sell
843
-35
-4% -$10.4K ﹤0.01% 198
2016
Q2
$212K Hold
878
– – ﹤0.01% 195
2016
Q1
$229K Sell
878
-249
-22% -$65.8K ﹤0.01% 184
2015
Q4
$345K Buy
+1,127
New +$324K 0.01% 161
2015
Q3
– Sell
-628
Closed -$254K – 214
2015
Q2
$254K Sell
628
-2,192
-78% -$880K ﹤0.01% 195
2015
Q1
$1.19M Buy
2,820
+47
+2% +$18.5K 0.02% 139
2014
Q4
$941K Sell
2,773
-1,419
-34% -$459K 0.02% 135
2014
Q3
$1.39M Buy
4,192
+1,474
+54% +$486K 0.02% 126
2014
Q2
$857K Buy
2,718
+650
+31% +$196K 0.01% 139
2014
Q1
$633K Buy
2,068
+522
+34% +$166K 0.01% 152
2013
Q4
$432K Buy
+1,546
New +$400K 0.01% 170

Other funds holding BIIB

Guardian Capital (Canada)'s BIIB Position: Q2 2018 in Review

Guardian Capital (Canada) sold out of Biogen (BIIB) in Q2 2018, closing a stake of 1,343 shares — an estimated $367K sold.

Guardian Capital (Canada) first reported a position in BIIB in Q4 2013 and held it in 15 quarters. The position peaked at $1.39M in Q3 2014. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Guardian Capital (Canada) reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Guardian Capital (Canada) sold 1,343 Biogen shares in Q2 2018, an estimated $367K.
  • Guardian Capital (Canada) first reported a position in Biogen in Q4 2013 and held it in 15 quarters.
  • Guardian Capital (Canada)'s Biogen position peaked at $1.39M in Q3 2014.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2018, filed 14 Aug 2018.